QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study

Abstract

BackgroundHome blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. ObjectiveThe purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. MethodsThe sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. ResultsThe analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. ConclusionsThis paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.